Latest on-demand webinars

Emerging and re-emerging infections among migrants

This ISAC webinar focused on respiratory infectious diseases in refugees, providing insight into the epidemiology, prevention, and management of important pathogens. Dr Androulla Efstratiou, Director of the WHO Collaborating Centre for Diphtheria & Streptococcal Infections, UK Health Security Agency, presented on diphtheria and other vaccine preventable diseases, while Dr Aula Abbara, a consultant in Infectious Diseases and General Internal Medicine at Imperial College NHS Healthcare Trust, London, who has worked in many humanitarian and refugee settings in the Middle East, reviewed drug resistant tuberculosis among refugees and migrants.

Advances in non tuberculous mycobacteria and new risks for public health

In this webinar, Dr Emmanuelle Cambau provided an insightful overview of non-tuberculous mycobacteria, highlighting what’s new on the horizon, while Dr Jakko van Ingen presented an update on the diagnosis and treatment of Mycobacterium abscessus infections which are increasing, particularly in immunocompromised patients or those with comorbidities.

This is a must-watch event for anyone interested in the latest developments and challenges in this evolving field.

Antimicrobial stewardship in critical care units

Hear from ISAC President Prof. Souha Kanj and three renowned international experts as they explore cutting-edge strategies to optimise antimicrobial use in ICUs in this webinar hosted by ISAC and the Alliance for the Prudent Use of Antibiotics (APUA).
Gain insights on balancing effective treatment with resistance prevention in high-risk settings. A must-watch for infectious disease specialists, intensivists and pharmacists.
The aim of this session is to enhance your stewardship practices and improve patient outcomes.

Antibiotic susceptibility patterns used for epidemiologic surveillance of Staphylococcus aureus

Organised by the MRSA Working Group

There have been recent studies in the US and Spain showing emerging resistance in MSSA to macrolides and to tetracyclines. ST398 S. aureus strains, initially identified as “livestock associated MRSA” are a fascinating example. Studies of clinical S. aureus strains have in some cases included molecular epidemiology suggesting that ST398 S. aureus strains may be responsible for a change in the relative prevalence of strains causing clinically significant disease. Other studies have examined national or transnational emergence of various increasingly common strains of MRSA and MSSA, using susceptibility patterns to track strain emergence or change over time. Listen to this webinar and hear from 3 experts in the field on these topics.

Optimising paediatric antibiotic therapy: a model-informed precision dosing approach

Organised by the ISAC Early Career Working Group

This session delves into the cutting-edge methodologies of model-informed precision dosing (MIPD) to enhance antibiotic treatment in children. Discover how integrating pharmacometric models and clinical data can optimise dosing regimens, improve therapeutic outcomes, and minimise adverse effects. Ideal for healthcare professionals, researchers, and clinicians, this webinar will provide valuable knowledge and practical strategies to revolutionise paediatric antibiotic therapy. Don't miss this opportunity to learn from the leading expert in the field and advance your practice.

Antifungal resistance in Candida and Aspergillus

Fungal infections, in their various manifestations, affect millions of people worldwide and cause a very high morbidity and mortality.
The new threats in the field of invasive mycoses and the new drugs recently available are reviewed in this webinar by internationally recognised experts.

One health aspects of AMR and infections in Asia

Organised by APSCMI / ISAC

The COVID-19 pandemic is a stark reminder of the importance of One Health approach to combat major challenges in infectious diseases. For this webinar we have focused on One Health and emerging infections from the Asia Pacific.

Antimicrobial resistance is a slow-burn pandemic that cannot be solved without multisectoral One Health approach. Nipah virus and severe fever with thrombocytopenia syndrome (SFTS) caused by tick-borne Bandavirus are emerging viral infections of significant mortality in South and East Asia respectively.

This webinar brings experts from the Asia Pacific to share on these three areas to stimulate dialogue and collaboration in our international infectious disease community.

Rapid diagnostics and strain typing in the era of antimicrobial resistance

Organised by the Rapid Diagnostics & Biomarkers Working Group

The aim of this recent webinar is to learn from current experiences across the globe on how rapid diagnosis impacts on curbing antimicrobial resistance (AMR).

Ortho spinal infections in the era of increasing AMR

This webinar was organised by organised by ISAC's Bone, Skin & Soft Tissue Working Group.

The aim is to learn from current experiences across the globe on how to manage ortho spinal infections and provide insight into novel diagnostics, antibiotics and antibiotic alternatives.

Phage pharmacology & therapy

This webinar was organised by International Society of Anti-Infective Pharmacology (ISAP), ESCMID PK/PD of Anti-Infectives Study Group (EPASG) and ISAC's Anti-Infective Pharmacology Working Group.

Antimicrobial resistance (AMR) poses a major global health concern. With antibiotics losing their stand against AMR, bacteriophages (phages; bacteria-eating viruses) have emerged as a promising antibacterial strategy.

In this webinar, a panel of speakers discussed the journey of phage therapy, spanning from ‘benchside’ to ‘bedside’, while also delving into the intricate pharmacological aspects to enhance clinical use of phages.

H5N1 Avian Influenza: the path from panzootic to pandemic

Organised by ISAC's Zoonoses Working Group

The recent global expansion of a novel avian influenza H5N1 strain is characterised by enhanced avian species adaptations, leading to mass mortality events, even threatening extinction of certain species. The strain has also been adapting to mammals with similar mass mortality events for certain species, and furthermore has been expanding to novel territories, particularly the Americas. Its mammal adaptation raises concerns for its potential to adapt to humans, facilitating human to human transmission and a pandemic. The evolutionary steps needed though are multiple. Yet, a H5N1 pandemic is a plausible future scenario, one that needs approaches and preparations specific for H5N1.